Yong-Joon Cho
Fortuna: 23 M $ al 30/09/2026
Fortuna: 23 M $ al 30/09/2026
Yong-Joon Cho is currently Chairman & Chief Executive Officer at DongKoo Bio & Pharm Co. Ltd. and Non-Executive Director at Qurient Co., Ltd. Formerly, Mr. Cho was Co-Chief Executive Officer & Director at TS Nexgen Co., Ltd. and Chief Executive Officer at Dongkoo Green Mart Co., Ltd. Education includes undergraduate and graduate degrees from Korea University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
DONGKOO BIO & PHARM CO. LTD. 28,35 % | 22/10/2026 | 8.068.463 ( 28,35 % ) | 21 M $ | 30/09/2026 |
QURIENT CO., LTD. 0,29 % | 04/08/2026 | 109.280 ( 0,29 % ) | 2 M $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| DONGKOO BIO & PHARMA CO., LTD. | Director Ejecutivo | 30/12/2005 |
| QURIENT CO., LTD. | Director/Miembro de la Junta | 26/09/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
| TS NEXGEN CO., LTD. | Director Ejecutivo | - |
Dongkoo Green Mart Co., Ltd. | Director Ejecutivo | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Korea University
Korea University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TS Nexgen Co., Ltd.
TS Nexgen Co., Ltd. Telecommunications EquipmentElectronic Technology Manufactures and sells dampers, generators, power distribution systems and energy storage systems & provides solar energy services | Electronic Technology |
DongKoo Bio & Pharm Co. Ltd.
DongKoo Bio & Pharm Co. Ltd. Pharmaceuticals: GenericHealth Technology Manufactures pharmaceutical products | Health Technology |
Qurient Co., Ltd.
Qurient Co., Ltd. BiotechnologyHealth Technology Engages in researching, developing, commercializing and selling of medicines | Health Technology |
Dongkoo Green Mart Co., Ltd. |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.